This $44 Billion High-Yield Stock Could Be In Trouble
March 23, 2011 at 09:00 AM EDT
It's one of the largest pharmaceutical companies in the world. I added the shares to my High-Yield Investing portfolio in January 2009. Over the following two years, I received $2.54 a share in dividends thanks to a 5% yield. Meanwhile, the price rose steadily for a gain of more than 40%. Dividends . . . → Read More: This $44 Billion High-Yield Stock Could Be In Trouble
